ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
TET2 |
Q6N021
|
tet methylcytosine dioxygenase 2
|
|
4.3E-54 |
0.458 |
0.808 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
CSF3R |
Q99062
|
colony stimulating factor 3 receptor
|
Signaling
|
1.5E-10 |
0.550 |
0.692 |
SOAT1 |
P35610
|
sterol O-acyltransferase 1
|
Enzyme
|
7.4E-10 |
0.424 |
0.846 |
IL3 |
P08700
|
interleukin 3
|
|
2.6E-09 |
0.489 |
0.731 |
MPL |
P40238
|
MPL proto-oncogene, thrombopoietin receptor
|
Receptor
|
4.1E-09 |
0.510 |
0.692 |
RARS1 |
P54136
|
arginyl-tRNA synthetase 1
|
|
3.3E-08 |
0.604 |
0.538 |
SCT |
P09683
|
secretin
|
|
1.4E-07 |
0.484 |
0.846 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
ABCB1 |
P08183
|
ATP binding cassette subfamily B member 1
|
Transporter
|
1.3E-05 |
0.344 |
0.885 |
VEGFA |
P15692
|
vascular endothelial growth factor A
|
Signaling
|
2.4E-05 |
0.266 |
0.923 |
TBC1D9 |
Q6ZT07
|
TBC1 domain family member 9
|
Enzyme
|
2.8E-05 |
0.399 |
0.846 |
CNTNAP1 |
P78357
|
contactin associated protein 1
|
|
3.4E-05 |
0.554 |
0.577 |
PRSS27 |
Q9BQR3
|
serine protease 27
|
Enzyme
|
8.0E-05 |
0.805 |
0.154 |
GSTT1 |
P30711
|
glutathione S-transferase theta 1
|
|
1.5E-04 |
0.393 |
0.923 |
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
FGFR1OP |
O95684
|
FGFR1 oncogene partner
|
|
6.3E-04 |
0.656 |
0.577 |
GSTM1 |
P09488
|
glutathione S-transferase mu 1
|
|
2.1E-03 |
0.380 |
0.923 |
AURKB |
Q96GD4
|
aurora kinase B
|
Kinase
|
4.5E-03 |
0.510 |
0.769 |
DNER |
Q8NFT8
|
delta/notch like EGF repeat containing
|
|
0.19 |
0.493 |
0.769 |
THPO |
P40225
|
thrombopoietin
|
|
0.20 |
0.513 |
0.692 |
CSF3 |
P09919
|
colony stimulating factor 3
|
|
0.38 |
0.377 |
0.885 |